ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Neurobiology of Opioid Dependence: 1 - 1

This study has been completed.

Sponsors and Collaborators: National Institute on Drug Abuse (NIDA)
Yale University
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00000192
  Purpose

The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.


Condition Intervention Phase
Opioid-Related Disorders
Drug: Lamotrigine
Phase II

Drug Information available for:   Lamotrigine   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Double-Blind, Placebo Control
Official Title:   Neurobiology of Opioid Dependence: 1

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Behavioral, subjective, measures of naloxone-precipitated opiate withdrawal
  • Phsyiological, neuroendocrine measures of naloxone-precipitated opiate withdrawal

Estimated Enrollment:   0
Study Start Date:   January 1995

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Please contact site for information.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000192

Locations
United States, Connecticut
VA Connecticut Healthcare System    
      New Haven, Connecticut, United States, 06519

Sponsors and Collaborators

Investigators
Principal Investigator:     Marc I Rosen, M.D.     VA Connecticut Healthcare System    
  More Information


Publications:
Rosen, MI et al; Drug and Alcohol Dependence, 1998: 52:p173-176. CPDD, 1996 Meeting.
 

Study ID Numbers:   NIDA-00191-1, K20-00191-1
First Received:   September 20, 1999
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00000192
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Mental Disorders
Lamotrigine
Substance-Related Disorders
Disorders of Environmental Origin
Opioid-Related Disorders

Additional relevant MeSH terms:
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Therapeutic Uses
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Anticonvulsants
Pharmacologic Actions

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers